Effect of long-term adherence on faecal immunochemical test positivity rate, positive predictive value and detection rate in organised population-based colorectal cancer screening
Top Cited Papers
Abstract
Background: Long-term adherence and results with faecal immunochemical test (FIT)-based colorectal cancer (CRC) screening are poorly characterised. Objective: To characterise adherence and results through seven rounds in an organised biennial FIT-based CRC screening programme. Design: We determined per-round FIT-completion, FIT-positivity, CRC and high-risk-CRC precursor positive predictive values (PPVs) and CRC detection/1000-FIT-participants for all invitees versus an adherent cohort (entry 50–51 years; 66–100% rounds completed) versus comparable-age first-ever screenings from 2010 to 2023. Joinpoint and multivariable logistic regression analyses identified trends. Results: Adherence was consistent, frequent, occasional, infrequent and never (defined as 100%, 66–99%, 33–65%, 1–32%, 0% of rounds offered) in 29.2%, 8.6%, 11.5%, 4.5% and 46.2% of 2.81 million individuals, respectively. In both the all-invitee population and the adherent cohort, the first round yielded the highest FIT positivity (5.8%, 4.4%), PPVs for CRC (5.1%, 3.3%) and high-risk precursors (20.4%, 13.1%), and CRC detection rates (2.65, 1.30 per 1000 participants), respectively. Beyond three rounds, outcomes stabilised at levels substantially lower than those observed in first-time screeners of the same age (eg, CRC-PPV in seventh round: 1.6–2.2% at median age 62–65 vs 6.6% for new screeners aged 62–63). Colonoscopy completion after a positive FIT was high (87.3%). Conclusion: After an initial round with the highest FIT-positivity and detection rates, screening outcomes stabilise at lower levels reflecting neoplasia removal and subsequent selection of a lower-risk population. Because detection rates remain clinically relevant even in an adherent cohort, early screening cessation after a sequence of normal biennial FITs is not justified.Keywords
Funding Information
- Agència de Gestió d'Ajuts Universitaris i de Recerca (2021SGR716)
- Instituto de Salud Carlos III
- Gorrindo Family Research Fund
- Fundación Científica Asociación Española Contra el Cáncer (GCB13131592CAST)
This publication has 27 references indexed in Scilit:
- Effect of invitation to colonoscopy versus faecal immunochemical test screening on colorectal cancer mortality (COLONPREV): a pragmatic, randomised, controlled, non-inferiority trialThe Lancet, 2025
- Can molecular cancer signals circulating in blood help us prevent cancer-related deaths?The Lancet, 2025
- Multitarget Stool RNA Test for Colorectal Cancer ScreeningJAMA, 2023
- Engaging European society at the forefront of cancer research and careMolecular Oncology, 2023
- Risk prediction for advanced neoplasia using longitudinal adherence measures to fecal immunochemical test-based colorectal cancer screening programsPreventive Medicine, 2023
- Longitudinal Oral Anticoagulant Adherence Trajectories in Patients With Atrial FibrillationJACC, 2021
- Results of Compliant Participation in Five Rounds of Fecal Immunochemical Test Screening for Colorectal CancerClinical Gastroenterology and Hepatology, 2021
- Measures of longitudinal adherence to fecal‐based colorectal cancer screening: Literature review and recommended approachesInternational Journal of Cancer, 2021
- Colorectal Cancer Early Screening Program of Barcelona, Spain: Indicators of the first round of a program with participation of community pharmaciesMedicina Clínica (English Edition), 2015
- High Rate of Advanced Adenoma Detection in 4 Rounds of Colorectal Cancer Screening With the Fecal Immunochemical TestClinical Gastroenterology and Hepatology, 2012